PATENT CLAIM ANALYSIS

Application Number: 15989414
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-02
Patent Classification: ["514", "300000"]

Abstract:
The present disclosure relates to solid forms of N-{[2′-(2,6-difluoro-3,5-dimethoxyphenyl)-3′-oxo-2′,3′-dihydro-1′H-spiro[cyclopropane-1,4′-[2,7]naphthyridin]-6′-yl]methyl}acrylamide, methods of preparation thereof, and intermediates in the preparation thereof, which are useful in the treatment of the FGFR-associated or mediated diseases such as cancer.

Claim (Index 6):
The solid form of  claim 3  having at least two characteristic XRPD peaks selected from about 8.1, about 9.0, about 11.5, about 12.3, about 15.1, about 16.0, about 18.0, about 19.6, about 20.0, about 20.4, about 21.0, about 23.3, about 24.2, about 24.7, and about 27.1 degrees 2-theta.

Metadata:
- Claim Count in Document: 146.0
- Percentile: 93.0
- Lexical Diversity: 1.29545
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15626539', '15856845', '14945147', '13962745', '15502639']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.812501693700664
- 35 USC 102 Novelty (BERT): 0.4981764798204755
- Combined Prediction Score: 0.7810691723126453
- Mean Citation Score: 245.044878
- Max Citation Score: 259.8712
- Similarity Product: 218.31083781766893

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test